checkmate 171: phase 2 trial of nivolumab for advanced squamous cell non-small cell lung cancer
Published 8 years ago • 161 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
2:01
checkmate 172 trial of nivolumab for advanced melanoma: preliminary results
-
3:52
checkmate 025: phase 3 trial of nivolumab for advanced kidney cancer
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
1:36
quality of life and symptom control for non-squamous nsclc patients on nivolumab (checkmate 057)
-
7:16
checkmate 9la study: nivo ipi in nsclc
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
4:04
update from checkmate 057: nivolumab versus docetaxel in advanced non-squamous nsclc
-
1:45
updates from checkmate 017 and checkmate 057: nivolumab, anti-pd1, for non-small cell lung cancer
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
1:19
29-month follow-up from checkmate 648: nivolumab combination therapy in escc
-
3:30
checkmate 9la: tmb and immune checkpoint inhibitor efficacy
-
1:49
sclc hyperprogression with nivolumab
-
8:23
nivolumab extends survival for nsclc
-
5:49
nivolumab extends survival for patients with the most common lung cancer
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc
-
1:24
checkmate 77t: perioperative nivolumab in nsclc - onctalk lung 2023
-
3:22
can immunotherapy improve survival in relapsed nsclc patients?
-
2:21
expert comment: the checkmate 227 study | sanjay popat
-
5:43
checkmate 9la trial on nivolumab plus ipilimumab for nsclc